Selecting the optimal design for drug discontinuation trials in a setting of advanced, life-limiting illness [1]

2015

JAMA Internal Medicine , Volume 175 - Issue 10 p. 1724- 1725

Additional Metadata
Persistent URL	doi.org/10.1001/jamainternmed.2015.3997, hdl.handle.net/1765/83406
Journal	JAMA Internal Medicine
Organisation	Department of Pharmacy
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Geijteman, E., Tiemeier, H., & van Gelder, T. (2015). Selecting the optimal design for drug discontinuation trials in a setting of advanced, life-limiting illness [1]. JAMA Internal Medicine, 175(10), 1724–1725. doi:10.1001/jamainternmed.2015.3997

Publication